At the 31st Annual Meeting of Japan Society of Gene and Cell Therapy (JSGCT2025), scheduled to start on July 23rd in 2025, Hamamatsu University School of Medicine -our collaborative research partner- will present two new research findings related to the development of novel therapies for brain tumors using SHED (stem cells from human exfoliated deciduous teeth).

Presentation 1: Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against glioblastoma stem cell

Presentation 2: Potential for enhanced oncolytic HSV-1 therapy via SHED as a vehicle against malignant gliomas


The 31st Annual Meeting of Japan Society of Gene and Cell Therapy (JSGCT2025) website
https://square.umin.ac.jp/jsgct2025/en/index.html
Related releases
November 7th, 2022
Announcement of publication of the research articles in collaboration with Hamamatsu University School of Medicine  - Proof of concept of the potential therapeutic application of next generation SHED for brain cancer - 
November 28th, 2022
Announcement of publication of the third research article in collaboration with Hamamatsu University School of Medicine - Proof of concept of the potential therapeutic application of next generation SHED for brain cancer –